U S PHYSICAL THERAPY INC /NV · Health Services

USPH

Low riskNext report: Around Nov 5 (est.)

View price ↗

The short version

A profitable company with steady sales.

Going well

Profitable every year for 10 years
Sales up 16% last year
Brings in more cash than it spends

Watch out for

Share count growing 5.3% a year

Money moves

No insider buying or selling in the last 30 days
Institutions added 0.9% to their holdings in the quarter ending June 2026 (97 bought, 124 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$88.78+0.4% that day

Company value: $1.3B; Share price times all shares
Price vs profit (P/E): 493.2x; You pay about $493 for each $1 of yearly profit
Price vs sales: 1.6x; Company value is 1.6 times a year of sales
Dividend yield: 2.0%; Yearly dividend as a share of today's price
Cash vs value: 2%; Cash as a share of company value
Debt vs value: 12%; Debt as a share of company value

From USPH's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$214.1M+8.5% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $812.2M, up 11% from the 12 months before. Over 5 years, sales grew about 13% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of USPH. Starting points are the company's recent numbers.

Sales growth+11% a yearRecently: +11% a yearProfit margin4%Last 12 months: 4.0%P/E at the end40xToday: 493.2x. Many steady companies trade at 12x to 25xShare count change+6% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$1.4B

Profit in 5 years$55M

Price these guesses point to$109.65+24% vs $88.78 todayAbout +4.3% a year, before dividends

What today's price needs: with a 4% margin and a 40x P/E, sales would have to grow about 6.4% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/7Mixed

MissReturn on equity 15%+Earns a lot on the money owners have in the business.8.2%
PassDebt under half of equityNot relying on borrowed money.0.34x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.5.1%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$75.1M
MissShare count not growingNot diluting owners. Falling means buybacks.+16.9% in 3 years
MissGross margin 40%+Pricing power: sells for well above what it costs to make.19.2%

Revenue: $781.0M; +16.3% vs prior year
5-year growth: +13.0%/yr; revenue, per year
Total debt: $162.5M; 0.34x equity
Current ratio: 1.01x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.